On the occasion of the 33rd edition of the Telethon, which takes place on Friday and Saturday, France Television devotes 30 hours of program to the collection of donations to finance research on genetic diseases. Sophie Davant and Nagui will be at the presentation, Jean-Paul Rouve is the godfather. The latter has entrusted his "pride" to Philippe Vandel's microphone on Europe 1.

INTERVIEW

The 33rd edition of the Telethon takes place on Friday and Saturday. A weekend that will mobilize again the antennas of France Televisions. In all, more than 30 hours of program will be devoted to the collection of donations to fund research on genetic diseases.

Sophie Davant and Nagui will be at the presentation. And by their side, it is the actor Jean-Paul Rouve who will have the heavy burden to ensure the role of godfather. At the microphone of Philippe Vandel, on Europe 1, he explains why he accepted the proposal.

>> Find all Philippe Vandel's programs in replay and podcast here

Jean-Paul Rouve wants to be a showcase that brings together

"How can you refuse? It's an honor, a pride, a responsibility. I've always been a telethon. When they offered me, I said 'yes, yes, with great pleasure'," says the one. who has been watching the telethon since he was a kid. After already three participations in the event and getting closer to several sick children, the actor appears more motivated than ever.

"I'm not in the idea of ​​breaking records for donations, it does not mean anything, you have to be there to explain, to give joy, a good mood. the godfather is there to be a showcase, a showcase that brings together, "he theorizes.

"Progress on these diseases reflects on widespread diseases"

In 2018, the event raised nearly 86 million euros, a lower balance sheet. "We can pride ourselves on France Television to create a national event that creates social bonds, it allows people to meet, to work together for a cause that will ultimately concern them too", also advance Sophie Davant on Europe 1 And to emphasize: "Because advances in research on these rare diseases also affect more widespread diseases".